Compare GSK plc (GSK) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Prudential Financial Inc — how do they compare? GSK plc trades at $52.66 (market cap $101.34B), while Prudential Financial Inc trades at $117.44 (market cap $39.96B). The key difference: GSK plc is far larger — about 2.5× Prudential Financial Inc's market cap, and Prudential Financial Inc pays the higher dividend (4.87%). Which is the better fit depends on your goals.
| GSK | PRU | |
|---|---|---|
Market Cap | $101.34B | $39.96B |
Sector | Health | Financials |
52-Week High | $61.18 | $118.72 |
52-Week Low | $36.20 | $92.00 |
Enterprise Value | $121.95B | $67.01B |
Dividend Yield | 3.49% | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Prudential Financial (PRU) trades at $114.79, down 1.19% on the day, with a bullish technical signal from moving averages but neutral oscillators. The stock shows strong fundamentals with a P/E of 11.85 and net income margin of 5.5%, supported by recent earnings beats. Recent news highlights retirement growth and international expansion, while a $1.40 dividend reinforces shareholder returns.
The outlook remains positive given earnings momentum and discounted valuation, though mixed analyst ratings and volatile cash flows pose risks. Upside potential hinges on continued execution in retirement services, while macroeconomic sensitivity and debt levels warrant monitoring for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
